Want to join the conversation?
$SBUX said that for FY16 foreign exchange is now expected to be a negative impact on revenue growth by 2 points and negatively impact non-GAAP EPS growth by 3 points. The company expects investments in its partners and digital initiatives to total between $275MM and $300MM globally in FY16 vs. approx. $145MM in FY15.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.